Opinion: More pain to come?
MS Amlin is a name which currently looms large in the minds of
Lloyd's underwriters.
Once the poster child of the Lloyd's market, its fall from
grace has been spectacular.
Its 2017 combined ratio of 137 percent was 23 points worse than
the Lloyd's market average following a spike in catastrophe
claims and a bout of reserve strengthening. This triggered a
group-wide review of underperforming lines and a targeted 10
percent reduction in full-time headcount.
MS Amlin's annus horribilis may...
Read more »